UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 3 | March 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 10 Issue 1
January-2023
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2301163


Registration ID:
507071

Page Number

b429-b432

Share This Article


Jetir RMS

Title

Gliclazide Extended Release dosage form of Anti- diabetic Drugs : A Review

Abstract

: In the present day many research did on extended release formulation. Different type of drug release mechanism used to formulate extended release tablets like matrix, Hot melt granulation, and pellet technology are used for gliclazide investigation. Gliclazide come under the sulphonyureaclass of anti- diabetic drugs. An extended release dosage form help in reduce the undesirable effects that may occur by peak effect of drugs. It helps to maintain the drug concentration in blood. Very analytical validation was done for made the extended release dosage form of gliclazide like preformulation studies, formulation and evaluation , stability studies, bioequivalence studies etc.

Key Words

Extended Release, Gliclazide, Organoleptic, Diabetes mellitus.

Cite This Article

"Gliclazide Extended Release dosage form of Anti- diabetic Drugs : A Review", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.10, Issue 1, page no.b429-b432, January-2023, Available :http://www.jetir.org/papers/JETIR2301163.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Gliclazide Extended Release dosage form of Anti- diabetic Drugs : A Review", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.10, Issue 1, page no. ppb429-b432, January-2023, Available at : http://www.jetir.org/papers/JETIR2301163.pdf

Publication Details

Published Paper ID: JETIR2301163
Registration ID: 507071
Published In: Volume 10 | Issue 1 | Year January-2023
DOI (Digital Object Identifier):
Page No: b429-b432
Country: Jaipur, Rajasthan, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

00075

Print This Page

Current Call For Paper

Jetir RMS